反応式
[CH2:1]1[C@@H:5]([OH:6])[C@H:4](/[CH:7]=[CH:8]/[C@@H:9]([OH:22])[CH2:10][O:11][C:12]2[CH:17]=[C:16]([C:18]([F:21])([F:20])[F:19])[CH:15]=[CH:14][CH:13]=2)[C@@H:3]([CH2:23]/[CH:24]=[CH:25]\[CH2:26][CH2:27][CH2:28][C:29]([OH:31])=[O:30])[C@H:2]1[OH:32].[NH2:33][C@H:34]([C:43]([OH:45])=[O:44])[CH2:35][CH2:36][CH2:37][CH2:38][NH:39][C:40]([NH2:42])=[NH:41]>CO.O>[CH3:35][CH:34]([O:30][C:29]([CH2:28][CH2:27][CH2:26]/[CH:25]=[CH:24]\[CH2:23][C@@H:3]1[C@@H:4](/[CH:7]=[CH:8]/[C@@H:9]([OH:22])[CH2:10][O:11][C:12]2[CH:13]=[CH:14][CH:15]=[C:16]([C:18]([F:21])([F:20])[F:19])[CH:17]=2)[C@H:5]([OH:6])[CH2:1][C@@H:2]1[OH:32])=[O:31])[CH3:43].[NH2:33][C@H:34]([C:43]([OH:45])=[O:44])[CH2:35][CH2:36][CH2:37][CH2:38][NH:39][C:40]([NH2:42])=[NH:41]参加物
4
実験手順
To travoprost free acid ((+)-fluprostenol free acid) 3 in MeOH/H2O is added L-Homoarginine and the solution is stirred for 30 minutes. The solvents are evaporated then azeotroped with Et2O and hexanes to give white crystalline travoprost-L-Homoarginine salt 5 (quantitative).
後処理
- customThe solvents are evaporated
- customthen azeotroped with Et2O and hexanes
出典と根拠
- ORDレコード
- ord-329ac80dce504053b0ad51bc4eddee3d
- 出典データセット
- uspto-grants-2014_01
- 特許番号
- US08623918B2
関連ノート
読み込み中…